IT202200005633A1 - Peptidi per la preparazione di vaccini contro sars-cov-2 - Google Patents
Peptidi per la preparazione di vaccini contro sars-cov-2 Download PDFInfo
- Publication number
- IT202200005633A1 IT202200005633A1 IT102022000005633A IT202200005633A IT202200005633A1 IT 202200005633 A1 IT202200005633 A1 IT 202200005633A1 IT 102022000005633 A IT102022000005633 A IT 102022000005633A IT 202200005633 A IT202200005633 A IT 202200005633A IT 202200005633 A1 IT202200005633 A1 IT 202200005633A1
- Authority
- IT
- Italy
- Prior art keywords
- cov
- peptides
- preparation
- vaccines against
- against sars
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000005633A IT202200005633A1 (it) | 2022-03-22 | 2022-03-22 | Peptidi per la preparazione di vaccini contro sars-cov-2 |
PCT/IB2023/052829 WO2023180966A1 (en) | 2022-03-22 | 2023-03-22 | Peptides for the preparation of vaccines against sars-cov-2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000005633A IT202200005633A1 (it) | 2022-03-22 | 2022-03-22 | Peptidi per la preparazione di vaccini contro sars-cov-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200005633A1 true IT202200005633A1 (it) | 2023-09-22 |
Family
ID=82100884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000005633A IT202200005633A1 (it) | 2022-03-22 | 2022-03-22 | Peptidi per la preparazione di vaccini contro sars-cov-2 |
Country Status (2)
Country | Link |
---|---|
IT (1) | IT202200005633A1 (it) |
WO (1) | WO2023180966A1 (it) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112034174A (zh) * | 2020-03-20 | 2020-12-04 | 中国人民解放军军事科学院军事医学研究院 | 一种多肽芯片及其在病毒检测上的应用 |
US20210000942A1 (en) * | 2018-06-12 | 2021-01-07 | Kentucky Bioprocessing, Inc. | Vaccines formed by virus and antigen conjugation |
WO2021249116A1 (en) * | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
-
2022
- 2022-03-22 IT IT102022000005633A patent/IT202200005633A1/it unknown
-
2023
- 2023-03-22 WO PCT/IB2023/052829 patent/WO2023180966A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210000942A1 (en) * | 2018-06-12 | 2021-01-07 | Kentucky Bioprocessing, Inc. | Vaccines formed by virus and antigen conjugation |
CN112034174A (zh) * | 2020-03-20 | 2020-12-04 | 中国人民解放军军事科学院军事医学研究院 | 一种多肽芯片及其在病毒检测上的应用 |
WO2021249116A1 (en) * | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2023180966A1 (en) | 2023-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT201900020422A1 (it) | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine | |
IT201800009683A1 (it) | Processo per la preparazione di 3α-idrossi-5α-pregnan-20-one (brexanolone) | |
PL3765431T3 (pl) | Ciągły lub półciągły sposób wytwarzania glikolu etylenowego | |
DK3840767T3 (da) | Peptider | |
MA53543A (fr) | Vaccins peptidiques | |
DK3886813T3 (da) | Farmaceutiske formuleringer af cyclosporinanaloger | |
IT202200005633A1 (it) | Peptidi per la preparazione di vaccini contro sars-cov-2 | |
DK3274447T3 (da) | Rekombinant fåresygevirus jeryl lynn 2 baseret vaccine | |
IT201800003376A1 (it) | Struttura per il confezionamento di contenitori ad uso farmaceutico | |
IT201900004729A1 (it) | Processo per la preparazione di midostaurina ad elevato grado di purezza | |
IT201900025348A1 (it) | Procedimento per la sintesi di melfalan | |
IT201700070742A1 (it) | Profilato per la realizzazione di serramenti | |
IT201900025195A1 (it) | Procedimento per la preparazione di zabaione | |
EP3993820A4 (en) | VACCINE BASED ON ANGPTL3 FOR THE TREATMENT OF LIVER DISEASES | |
IT202200010625A1 (it) | Impianto di essiccazione per la preparazione di impasti ceramici | |
IT201700050223A1 (it) | Procedimento per la preparazione di dexlansoprazolo cristallino | |
RU2017120942A (ru) | Адьювант для противовирусных вакцин | |
IT201900020350A1 (it) | Formulazione orodispersibile di vardenafil | |
IT202200002663A1 (it) | Macchina per la preparazione di bevande | |
ITUA20162489A1 (it) | Procedimento per la preparazione di toltrazuril e intermedio utile per la sua preparazione | |
GB202317903D0 (en) | Vaccine formulation | |
GB202117230D0 (en) | Peptide vaccine | |
IT201900024123A1 (it) | Procedimento per la produzione sincrona e programmata di pleurotus eryngii | |
IT201900020240A1 (it) | Procedimento per la preparazione di Filgotinib e intermedi di sintesi | |
GB202315888D0 (en) | Influenza vaccines |